EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson’s Disease

Maya Georgieva iD, Martin Sharkov, Emilio Mateev iD, Diana Tzankova iD, Georgi Popov, Vasil Manov iD, Alexander Zlatkov iD, Rumyana Simeonova iD, Magdalena Kondeva-Burdina iD

Molecules · 2025

DOI: 10.3390/molecules30153154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Maya Georgieva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Hydrazones, Pyrroles, Parkinson Disease, Neuroprotective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Some studies performed in our laboratory on pyrrole and its derivatives pointed towards the enrichment of the evaluations of these promising chemical structures for the potential treatment of neurodegenerative conditions in general and Parkinson’s disease in particular. A classical Paal-Knorr cyclization approach is applied to synthesize the basic hydrazine used for the formation of the designed series of hydrazones (15a–15g). The potential neurotoxic and neuroprotective effects of the newly synthesized derivatives were investigated in vitro using different models of induced oxidative stress at three subcellular levels (rat brain synaptosomes, mitochondria, and microsomes). The results identified as the least neurotoxic molecules, 15a, 15d, and 15f applied at a concentration of 100 µM to the isolated fractions. In addition, the highest statistically significant neuroprotection was observed for 15a and 15d at a concentration of 100 µM using three different injury models on subcellular fractions, including 6-hydroxydopamine in rat brain synaptosomes, tert-butyl hydroperoxide in brain mitochondria, and non-enzyme-induced lipid peroxidation in brain microsomes. The hMAOA/MAOB inhibitory activity of the new compounds was studied at a concentration of 1 µM. The lack of a statistically significant hMAOA inhibitory effect was observed for all tested compounds, except for 15f, which showed 40% inhibitory activity. The most prominent statistically significant hMAOB inhibitory effect was determined for 15a, 15d, and 15f, comparable to that of selegiline. The corresponding selectivity index defined 15f as a non-selective MAO inhibitor and all other new hydrazones as selective hMAOB inhibitors, with 15d indicating the highest selectivity index of >471. The most active and least toxic representative (15d) was evaluated in vivo on Rotenone based model of Parkinson’s disease. The results revealed no microscopically visible alterations in the ganglion and glial cells in the animals treated with rotenone in combination with 15d.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazonesPyrrolesParkinson DiseaseNeuroprotective AgentsAnimalsRatsCyclizationSynaptosomesMaleMitochondriaOxidative StressDisease Models, AnimalBrainLipid PeroxidationMonoamine Oxidase InhibitorsRats, Wistar

Stichwörter der Autor:innen

Parkinson’shydrazonein vivopyrrolesynthesis

Substanzen

HydrazonesPyrrolesNeuroprotective AgentsMonoamine Oxidase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University Sofia, 1000 Sofia, Bulgaria.
  • Department of Internal Non-Communicable Diseases, Pathology and Pharmacology, Faculty of Veterinary Medicine, University of Forestry, 10 St. Kliment Ohridski Blvd., 1797 Sofia, Bulgaria.
  • Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University Sofia, 1000 Sofia, Bulgaria.

ORCID-Profile: Maya Georgieva, Emilio Mateev, Diana Tzankova, Vasil Manov, Alexander Zlatkov, Rumyana Simeonova, Magdalena Kondeva-Burdina

Förderung

  • European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria

Zitieren

APA

Georgieva, M., Sharkov, M., Mateev, E., Tzankova, D., Popov, G., Manov, V., Zlatkov, A., Simeonova, R., & Kondeva-Burdina, M. (2025). Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson’s Disease. Molecules. https://doi.org/10.3390/molecules30153154

Vancouver

Georgieva M, Sharkov M, Mateev E, Tzankova D, Popov G, Manov V, et al. Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson’s Disease. Molecules. 2025. doi:10.3390/molecules30153154

BibTeX
@article{Georgieva2025,
  author = {Georgieva, Maya and Sharkov, Martin and Mateev, Emilio and Tzankova, Diana and Popov, Georgi and Manov, Vasil and Zlatkov, Alexander and Simeonova, Rumyana and Kondeva-Burdina, Magdalena},
  title = {Classical Paal-Knorr Cyclization for Synthesis of Pyrrole-Based Aryl Hydrazones and In Vitro/In Vivo Evaluation on Pharmacological Models of Parkinson’s Disease},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30153154}
}
Kostenlos starten →